CA3063938A1 - Compounds, compositions and methods - Google Patents

Compounds, compositions and methods Download PDF

Info

Publication number
CA3063938A1
CA3063938A1 CA3063938A CA3063938A CA3063938A1 CA 3063938 A1 CA3063938 A1 CA 3063938A1 CA 3063938 A CA3063938 A CA 3063938A CA 3063938 A CA3063938 A CA 3063938A CA 3063938 A1 CA3063938 A1 CA 3063938A1
Authority
CA
Canada
Prior art keywords
optionally substituted
compound
alkyl
disease
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3063938A
Other languages
English (en)
French (fr)
Inventor
Giorgio Bonanomi
Anthony A. ESTRADA
Jianwen A. FENG
Brian Fox
Cinzia Maria FRANCINI
Cheng Hu
Colin Philip Leslie
Maksim OSIPOV
Anantha Sudhakar
Zachary K. Sweeney
Javier De Vicente Fidalgo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denali Therapeutics Inc
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Publication of CA3063938A1 publication Critical patent/CA3063938A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA3063938A 2017-05-17 2018-05-17 Compounds, compositions and methods Pending CA3063938A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762507682P 2017-05-17 2017-05-17
US62/507,682 2017-05-17
PCT/US2018/033269 WO2018213634A1 (en) 2017-05-17 2018-05-17 Compounds, compositions and methods

Publications (1)

Publication Number Publication Date
CA3063938A1 true CA3063938A1 (en) 2018-11-22

Family

ID=64274734

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3063938A Pending CA3063938A1 (en) 2017-05-17 2018-05-17 Compounds, compositions and methods

Country Status (11)

Country Link
US (2) US11174262B2 (enExample)
EP (1) EP3625234B1 (enExample)
JP (2) JP7140781B2 (enExample)
KR (1) KR102637541B1 (enExample)
CN (1) CN110914275A (enExample)
AU (2) AU2018269745C1 (enExample)
BR (1) BR112019023979A2 (enExample)
CA (1) CA3063938A1 (enExample)
IL (1) IL270505B2 (enExample)
MX (1) MX2019013642A (enExample)
WO (1) WO2018213634A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3552017B1 (en) * 2016-12-09 2022-02-23 Denali Therapeutics Inc. Compounds useful as ripk1 inhibitors
WO2018213634A1 (en) * 2017-05-17 2018-11-22 Denali Therapeutics Inc. Compounds, compositions and methods
WO2022046905A1 (en) * 2020-08-26 2022-03-03 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods of use
WO2023076133A1 (en) * 2021-10-27 2023-05-04 Merck Sharp & Dohme Llc Spirotricycle ripk1 inhibitors and methods of uses thereof
WO2025045281A2 (zh) * 2023-08-31 2025-03-06 杭州百诚医药科技股份有限公司 苯并氮杂䓬酮类化合物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320057A (en) * 1980-06-23 1982-03-16 American Home Products Corporation Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4290952A (en) * 1980-06-23 1981-09-22 American Home Products Corporation Aryl-1-mercaptoalkanoylproline and homoproline derivatives
CN1960728A (zh) 2004-01-16 2007-05-09 密歇根大学董事会 构象受限的smac模拟物及其应用
EP2457895A1 (en) 2004-07-12 2012-05-30 Idun Pharmaceuticals, Inc. Tetrapeptide analogs
BRPI0611922A2 (pt) 2005-06-08 2010-10-05 Novartis Ag compostos orgánicos
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
AU2007276760B2 (en) 2006-07-24 2012-01-19 Tetralogic Pharmaceuticals Corporation Dimeric IAP antagonists
JP6465803B2 (ja) 2012-10-22 2019-02-06 シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ Ｅｔｐ誘導体
US20150023913A1 (en) 2013-07-02 2015-01-22 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US9944628B2 (en) * 2014-12-11 2018-04-17 President And Fellows Of Harvard College Inhibitors of cellular necrosis and related methods
JP6683712B2 (ja) * 2014-12-24 2020-04-22 ナショナル・インスティチュート・オブ・バイオロジカル・サイエンシズ，ベイジン ネクローシス阻害薬
WO2018213634A1 (en) * 2017-05-17 2018-11-22 Denali Therapeutics Inc. Compounds, compositions and methods

Also Published As

Publication number Publication date
WO2018213634A1 (en) 2018-11-22
AU2018269745C1 (en) 2022-06-09
MX2019013642A (es) 2020-07-20
US11174262B2 (en) 2021-11-16
IL270505B2 (en) 2023-09-01
JP2020520925A (ja) 2020-07-16
IL270505A (enExample) 2019-12-31
CN110914275A (zh) 2020-03-24
IL270505B1 (en) 2023-05-01
AU2022202524A1 (en) 2022-05-12
EP3625234A4 (en) 2021-03-10
KR20200006120A (ko) 2020-01-17
US20200079784A1 (en) 2020-03-12
JP2022174180A (ja) 2022-11-22
AU2022202524B2 (en) 2023-10-05
AU2018269745A1 (en) 2019-11-28
JP7140781B2 (ja) 2022-09-21
EP3625234B1 (en) 2023-09-20
EP3625234A1 (en) 2020-03-25
KR102637541B1 (ko) 2024-02-15
AU2018269745B2 (en) 2022-01-27
US20220024938A1 (en) 2022-01-27
US11851433B2 (en) 2023-12-26
BR112019023979A2 (pt) 2020-06-09

Similar Documents

Publication Publication Date Title
US10709692B2 (en) Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)
AU2022202524B2 (en) Compounds, compositions and methods
US12180211B2 (en) Compounds, compositions and methods
AU2018346597B2 (en) Inhibiting Ubiquitin Specific Peptidase 30
CA3071024A1 (en) Compounds, compositions and methods
CA3012832A1 (en) N-azepinyl-carboxamide inhibitors of receptor-interacting protein kinase1
EP3624797A1 (en) Kinase inhibitors and uses thereof
JP2021524440A (ja) ユビキチン特異的ペプチダーゼ３０（ｕｓｐ３０）阻害剤として有用な縮合二環化合物
CA2970525A1 (en) Inhibitors of cellular necrosis and related methods
HK40016450B (en) Compounds useful as ripk1 inhibitors
WO2025260014A1 (en) Compounds, compositions, and methods
OA19864A (en) Compounds, compositions, and methods.

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220915

EEER Examination request

Effective date: 20220915

EEER Examination request

Effective date: 20220915

EEER Examination request

Effective date: 20220915

EEER Examination request

Effective date: 20220915